Cryptocurrency

Pakistan Crypto Regulation Faces Islamic Law Test After 'Haram' Ruling

15/07/2026

A leading cleric's ruling against crypto has prompted engagement from the country's digital asset regulator amid a broader push for formalisation.

Sustainable Finance

Taiwan Close to Reaching 2030 Green Finance Goal

15/07/2026

Regulators have used capital incentives and new certification schemes to drive investment, hitting 88 percent of the 2030 target ahead of schedule.

Market Risk

Hong Kong Finalises Review Mechanism for Insurance Rate Caps

14/07/2026

Hong Kong’s IA has detailed its review mechanism for illustration rate caps on participating policies, with the first review slated for 2027.

Cryptocurrency

Korea Approves Mirae Asset's Acquisition of Korbit Crypto Exchange

14/07/2026

The competition authority has cleared the deal, citing the exchange's low market share as a reason it is unlikely to harm competition.

Trading & Investment

China Sees Strong Demand for New Commercial Property REITs

14/07/2026

The successful launch of China's first commercial property REITs has prompted more than 20 new applications from developers and owners.

Supervision & Enforcement

ASIC Penalises Deutsche Bank for Derivatives Reporting Failures

14/07/2026

Deutsche Bank was penalised for misreporting over 260,000 OTC derivative transactions over a ten-month period.

Sustainable Finance

OJK Indonesia Issues New Rules for Carbon Exchange Trading

14/07/2026

The new regulation expands the scope of tradable units, mandates a new national registry, and introduces rules for foreign carbon credits.

Alternative Markets

India's PFRDA Forms Panel to Attract Global Pension Capital

14/07/2026

The expert committee will recommend a new regulatory and governance framework to facilitate partnerships between local and global pension funds.

Alternative Markets

Korea to Launch Public Asset Manager for Long-Term Tech Investment

14/07/2026

The new entity, designed to manage up to KRW 10 trillion, will target strategic sectors like AI and biotech to supply patient capital where private funding is scarce.